Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study

Cited by (156)

Items 101–156 of 156

  1. Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
    Stefan Hans Hohnloser, A. John Camm, Riccardo Cappato, Hans‐Christoph Diener, Hein Heidbüchel, Lluı́s Mont, Carlos Arturo Morillo, Hans‐Joachim Lanz, Heiko Rauer, Paul‐Egbert Reimitz et al. · 2020 · EP Europace
  2. Feasibility and safety of uninterrupted apixaban in patients undergoing radiofrequency ablation for atrial fibrillation
    Yuki Osaka, Yuichi Ono, Susumu Tao, Kentaro Goto, Toru Miyazaki, Asami Suzuki, Ken Kurihara, Kenichiro Otomo, Kenzo Hirao · 2019 · Journal of Interventional Cardiac Electrophysiology
  3. The Coagulation and Atrial Fibrillation Ablation Cascades
    Samuel J. Asirvatham, Martin van Zyl · 2019 · JACC. Clinical electrophysiology
  4. Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis
    Tabito Kino, Minako Kagimoto, Takayuki Yamada, Satoshi Ishii, Masanari Asai, Shunichi Asano, Hideto Yano, Toshiyuki Ishikawa, Tomoaki Ishigami · 2022 · Journal of Clinical Medicine
  5. Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation
    Peijun Li, Jun Xiao, Qing Zhen Yang, Yuan Feng, Ting Wang, Guanjian Liu, Zong-An Liang · 2016 · Journal of Interventional Cardiac Electrophysiology
  6. Atrial Fibrillation Ablation and Stroke
    Philip Aagaard, David Felipe Briceno, Zoltán Csanádi, Sanghamitra Mohanty, Carola Gianni, Chintan G. Trivedi, Edina Nagy-Baló, Stephan Danik, Conor D. Barrett, Francesco Santoro et al. · 2016 · Cardiology Clinics
  7. New migraine with visual disturbance after cryoballoon ablation of atrial fibrillation
    Annupreet Nadha, Eric S Williams · 2017 · Journal of Atrial Fibrillation
  8. Coagulation and heparin requirements during ablation in patients under oral anticoagulant drugs
    Philippe Maury, Slimane Belaid, Agnès Maurel Ribes, Quentin Voglimacci‐Stephanopoli, Pierre Mondoly, Marie Blaye, Franck Mandel, Benjamin Monteil, Didier Carrié, Michel Galinier et al. · 2020 · Journal of Arrhythmia
  9. Periprocedural Anticoagulation for Catheter Ablation of Atrial Fibrillation: Practical Implications for Perioperative Management
    David Felipe Briceno, Nidhi Madan, Pedro Arturo Villablanca, Florentino A. Lupercio, Nicole B. Cyrille, Harish Ramakrishna, Luigi Di Biase · 2017 · Journal of Cardiothoracic and Vascular Anesthesia
  10. Omitting transesophageal echocardiography before catheter ablation of atrial fibrillation
    Vera Maslova, Thomas Demming, Robert Pantlik, Tamás Géczy, Peter Falk, Bjoern Andrew Remppis, Derk Frank, Evgeny Lian · 2024 · Journal of Interventional Cardiac Electrophysiology
  11. How safe are NOACs compared with phenprocoumon after pulmonary vein isolation with the cryoballoon technique using purse-string suture closure?
    Ersan Akkaya, Alexander Berkowitsch, Sergej Zaltsberg, Nikolas Deubner, H. Greiß, Andreas Hain, Christian W. Hamm, Johannes Sperzel, Malte Kuniss, Thomas Neumann · 2017 · International Journal of Cardiology
  12. 2018 Korean Guidelines for Catheter Ablation of Atrial Fibrillation: Part I
    Hyoung‐Seob Park, Dong Seop Jeong, Hee Tae Yu, Hui‐Nam Pak, Jae‐Sun Uhm, Joo Yeon Kim, Jun Kim, Jung‐Myung Lee, Ki Hoon Kim, Seung‐Young Roh et al. · 2018 · International Journal of Arrhythmia
  13. Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
    Ilir Maraj, Mario Daniel Gonzalez, Gerald V. Naccarelli · 2018 · Journal of Innovations in Cardiac Rhythm Management
  14. Use of the CHA 2 DS 2 VASc score to reduce utilisation of transoesophageal echocardiography prior to ablation for atrial fibrillation
    Charlotte Atkinson, Jonathan Hinton, Edmund B Gaisie, ARTHUR M. YUE, Paul Richard Roberts, Dhrubo Jyoti Rakhit, Benoy Nalin Shah · 2017 · Echo Research and Practice
  15. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation
    Toby C. Trujillo, Paul P. Dobesh, George H. Crossley, Shannon W. Finks · 2018 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  16. Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures
    Jan Steffel · 2020 · European Heart Journal Supplements
  17. Thromboembolism and bleeding risk in atrial fibrillation ablation with uninterrupted anticoagulation between new oral anticoagulants and vitamin K antagonists: insights from an updated meta-analysis
    Xiaohua Liu, Xiaofei Gao, Chao-Feng Chen, Bin Chen, Yizhou Xu · 2019 · Journal of Thrombosis and Thrombolysis
  18. Effect of preventing air intrusion on silent strokes during atrial fibrillation ablation using a mini‐basket catheter
    Kohki Nakamura, Takehito Sasaki, Yutaka Take, Kentaro Minami, Wataru Sasaki, Shohei Kishi, Shingo Yoshimura, Yoshinori Okazaki, Yuko Miki, Koji Goto et al. · 2020 · Pacing and Clinical Electrophysiology
  19. Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation
    Zsuzsa Bagoly, Orsolya Hajas, Réka Urbancsek, Alexandra Kiss, Edit Fiák, Ferenc Sarkady, Noémi Klára Tóth, Rita Orbán-Kálmándi, Kitti Bernadett Kovács, László Nagy et al. · 2020 · Journal of Clinical Medicine
  20. Influence of ablation index on the incidence of cardiac tamponade complicating pulmonary vein isolation
    Nico Reinsch, Anna Füting, Jochen Buchholz, Ute Ruprecht, Kars G.E.J. Neven · 2020 · Herz
  21. Changes in plasma concentrations of edoxaban and coagulation biomarkers according to thromboembolic risk and atrial fibrillation type in patients undergoing catheter ablation: Subanalysis of KYU‐RABLE
    Tetsuji Shinohara, Naohiko Takahashi, Yasushi Mukai, Tetsuya Kimura, Keita Yamaguchi, Atsushi Takita, Hideki Origasa, Ken Okumura, the KYU‐RABLE Investigators · 2020 · Journal of Arrhythmia
  22. Meta-analysis of efficacy and safety of new oral anticoagulants compared with warfarin in Japanese patients undergoing catheter ablation for atrial fibrillation
    Yuchao Sun, Xiaohua Liu, Yizhou Xu · 2020 · Journal of Interventional Cardiac Electrophysiology
  23. Warfarin versus non-vitamin k antagonist oral anticoagulants: how the degree of coagulation differs during catheter ablation of atrial fibrillation
    Попылькова Оксана Васильевна, С. С. Дурманов, Mihir P. Patel, В. В. Базылев · 2022 · Journal of Arrhythmology
  24. Techniques to Avoid Complications of Atrial Fibrillation Ablation
    Nachiket Madhav Apte, Amit Shrestha, Raghuveer Dendi · 2020 · Current Treatment Options in Cardiovascular Medicine
  25. S1 Leitlinie – Österreichischer Konsensus zur Antikoagulation im Rahmen der Vorhofflimmerablation
    Arbeitsgruppe Rhythmologie der Österreichischen Kardiologischen Gesellschaft, Martin Martinek, Marianne Gwechenberger, Daniel Scherr, Clemens Steinwender, M Stuehlinger, Helmut Pürerfellner, Franz Xaver Roithinger, Lukas Fiedler · 2018 · Wiener klinische Wochenschrift
  26. Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures
    Shannon W. Finks, Paul P. Dobesh, Toby C. Trujillo, George H. Crossley · 2018 · Cardiology in Review
  27. WITHDRAWN: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
    Hugh G Calkins, Gerhard Hindricks, Riccardo Cappato, Young‐Hoon Kim, Eduardo Saad, Luis Aguinaga, Joseph G. Akar, Vinay Badhwar, Josép Brugada, A. John Camm et al. · 2017 · Journal of Arrhythmia
  28. Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation
    Hammad Rahman, Safi Ullah Khan, Michael DePersis, Tehseen Hammad, Fahad Nasir, Edo Kaluski · 2018 · Cardiovascular revascularization medicine
  29. 2018 Korean Guidelines for Catheter Ablation of Atrial Fibrillation: Part II
    Hee Tae Yu, Dong Seop Jeong, Hui‐Nam Pak, Hyoung‐Seob Park, Joo Yeon Kim, Jun Kim, Jung‐Myung Lee, Ki‐Hoon Kim, Nam Sik Yoon, Seung‐Young Roh et al. · 2018 · International Journal of Arrhythmia
  30. Periprocedural anticoagulation in patients undergoing cryoballoon ablation for atrial fibrillation
    Polychronis Dilaveris, Dimitris Tousoulis · 2016 · Hellenic Journal of Cardiology
  31. Femoral venous hemostasis after atrial fibrillation ablation: Is figure-of-eight suture the way to go?
    Syeda Atiqa Batul, Rakesh Gopinathannair · 2017 · Indian Pacing and Electrophysiology Journal
  32. Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation
    Jayasree Pillarisetti, Madhu Reddy, Mamatha Vodapally, Tulasi Annapureddy, Maruthsakhi Molugu, Donita Atkins, Sudharani Bommana, Rhea Pimentel, Raghuveer Dendi, Dhanunjaya Lakkireddy · 2020 · Indian Pacing and Electrophysiology Journal
  33. Symptomatic and asymptomatic intracerebral hemorrhages detected by magnetic resonance imaging after catheter ablation of atrial fibrillation
    Kohki Nakamura, Takehito Sasaki, Kentaro Minami, Yutaka Take, Koki Kimura, Yumiko Haraguchi, Wataru Sasaki, Shohei Kishi, Shingo Yoshimura, Yosuke Nakatani et al. · 2021 · Journal of Interventional Cardiac Electrophysiology
  34. A retrospective analysis of anticoagulant safety among heart transplant recipients undergoing endomyocardial biopsy
    James C. Stock, Jason Carlquist, Megan Melnyk, Sakima Ahmad Smith, Indra Bole, Vaiibhav N. Patel, Sitaramesh Emani, Beth A. Foreman, Ayesha Hasan, Verónica Franco et al. · 2024 · Clinical Transplantation
  35. Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation
    Rajiv Sankaranarayanan, David J. Fox · 2016 · Current Cardiology Reviews
  36. Evaluation of left atrial thrombus prior to catheter ablation of atrial fibrillation: Is it time for an individualized approach?
    Avishag Laish‐Farkash, Mahmoud A. Suleiman · 2017 · Journal of Cardiovascular Electrophysiology
  37. Innovative Approaches to Assess the Impact and Steps to Decrease the Neurological Consequences of Ablation
    Shiva Ponamgi, Omar Ziad Yasin, Deepak Padmanabhan, Christopher V. DeSimone, Samuel Asirvatham · 2016 · Journal of Innovations in Cardiac Rhythm Management
  38. Silent Cerebral Embolism After Catheter Ablation for Atrial Fibrillation – Unresolved Issue or Too Much Concern? –
    Teiichi Yamane · 2016 · Circulation Journal
  39. Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants?
    Jeffrey B. Washam, Jonathan Paul Piccini · 2015 · Journal of Thrombosis and Thrombolysis
  40. Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil
    Renato D. Lópes, Patrícia O. Guimarães, Elaine M. Hylek, Gilson Soares Feitosa-Filho, Luiz Eduardo Fonteles Ritt, Nivaldo Filgueiras, Eduardo Sahade Darzé, Mário de Seixas Rocha, L. P. Magalhães, Antônio Carlos Sobral Sousa et al. · 2017 · Journal of Thrombosis and Thrombolysis
  41. Are NOACs safer than phenprocoumon in patients undergoing pulmonary vein isolation with the cryoballoon technique using purse-string suture closure?
    Chao Sun, Fen Qin, Chaoshuo Liu, Fan Bai, Tao Tu, Zhihong Wu, Qiming Liu · 2018 · International Journal of Cardiology
  42. Véralvadásgátló kezelés elektrofiziológiai beavatkozások során
    Zoltán Som · 2017 · Cardiologia Hungarica
  43. Anticoagulant Strategies for Electrophysiology Procedures
    STUART J. BELDNER, David Lee Stern · 2018 · Springer eBooks
  44. Periablation Anticoagulation
    Prashanthan Sanders, Dian Andina Munawar, Rajeev Kumar Pathak · 2018 · JACC. Clinical electrophysiology
  45. Catheter Ablation
    Luigi Di Biase, Philip Aagaard, Pasquale Santangeli, Andrea Natale · 2017 · Elsevier eBooks
  46. A prospective multicenter study of direct comparison of feasibility and safety of pulmonary vein isolation using the minimally interrupted apixaban between second‐generation cryoballoon and radiofrequency ablation of paroxysmal atrial fibrillation: J‐HIT apixaban
    Atsuhiko Yagishita, Masahiko Goya, Yoshito Iesaka, Junichi Nitta, Atsushi Takahashi, Yasutoshi Nagata, Hitoshi Hachiya, Osamu Inaba, Yukihiro Inamura, Yasuaki Tanaka et al. · 2020 · Journal of Arrhythmia
  47. Embolic protection devices for stroke prevention during cardiac interventions
    Mohammed Imran Ghare, Shanshan Zhou, Daniela Tı̂rziu, Alexandra J. Lansky · 2020 · Elsevier eBooks
  48. Direct Oral Anticoagulants and Atrial Fibrillation Ablation
    Ahmed AlTurki, Riccardo Proietti, Vidal Essebag · 2021 · Springer eBooks
  49. Comparison of uninterrupted direct oral anticoagulation with vitamin‐K antagonists during AF ‐ablation in the clinical routine. A single center register
    Marian Christoph, Akram A. Youssef, Jan Svitil, Mathias Forkmann, Yan Huo, Thomas Gaspar, Alexander Francke, Steffen Schoen, Silvio Quick, Carsten Wunderlich · 2021 · Clinical Cardiology
  50. Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
    M. V. Serova, Denis A. Andreev, M. I. Chashkina, Z. K. Salpagarova · 2021 · CARDIOVASCULAR THERAPY AND PREVENTION
  51. Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study
    Shuyi Wu, Chengfu Guan, Wenlin Xu, Feilong Zhang, Nianxu Huang, Xia Chen, Wang Zhang, Wei Hu, Jun Su, Hengfen Dai et al. · 2023 · Thrombosis Journal
  52. Reducing Stroke Risk After Catheter Ablation of Ventricular Arrhythmias
    Naga Venkata K. Pothineni, Dhanunjaya Lakkireddy · 2024 · JACC. Clinical electrophysiology
  53. Contemporary atrial fibrillation management
    Martin Martinek · 2024
  54. Optimal anticoagulation strategy for atrial fibrillation ablation: are all direct oral anticoagulants and vitamin K antagonists the same? - a meta-analysis of embolic and bleeding complications in more than 31,500 patients
    Dan Laurentiu Musat, Bogdan Enache, Alexandra Musat, Advay G. Bhatt, Mohammadali Habibi, Stephanie Meller Kochav, Tina Sichrovsky, Mark W. Preminger, Suneet Mittal · 2025 · Romanian Journal of Cardiology
  55. Additional file 1 of Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study
    Wu, Shuyi, Chengfu Guan, Xu, Wenlin, Feilong Zhang, Nianxu Huang, Chen, Xia, Zhang, Wang, Hu, Wei, Jun Su, Hengfen Dai et al. · 2024 · Figshare
  56. Device-dependent activated clotting time measurements during transseptal ablation under continuous anticoagulation: Comparison of mechanical-optical and microfluidic electrochemical systems
    Konstantin Krieger, H. Allan Feller, Holger Krebbel, Jan Stepek, Ahmed El Shazly, Dimitrios Kolyvakis, Yvonne Dell, Alexander Wutzler · 2026 · Heart Rhythm O2